Octagon Capital Advisors LP Sana Biotechnology, Inc. Transaction History
Octagon Capital Advisors LP
- $639 Million
- Q1 2024
A detailed history of Octagon Capital Advisors LP transactions in Sana Biotechnology, Inc. stock. As of the latest transaction made, Octagon Capital Advisors LP holds 360,800 shares of SANA stock, worth $1.97 Million. This represents 0.56% of its overall portfolio holdings.
Number of Shares
360,800Holding current value
$1.97 Million% of portfolio
0.56%Shares
1 transactions
Others Institutions Holding SANA
# of Institutions
156Shares Held
124MCall Options Held
297KPut Options Held
124K-
Flagship Pioneering Inc. Cambridge, MA25MShares$137 Million16.48% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$66.4 Million0.0% of portfolio
-
Baillie Gifford & CO10.7MShares$58.2 Million0.08% of portfolio
-
Canada Pension Plan Investment Board Toronto Ontario, A610.2MShares$55.6 Million0.11% of portfolio
-
Black Rock Inc. New York, NY9.05MShares$49.4 Million0.0% of portfolio
About Sana Biotechnology, Inc.
- Ticker SANA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 190,232,000
- Market Cap $1.04B
- Description
- Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...